Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma

Documenti analoghi

• Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
  di: Zelin Weng, et al.
  Pubblicazione: (2024)
• Radiotherapy as an organ‐preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy
  di: Xin‐Yun Song, et al.
  Pubblicazione: (2025)
• Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi
  di: Bongani Kaimila, et al.
  Pubblicazione: (2024)
• The transcriptional landscape and clinico‐biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma
  di: Xinrui Shi, et al.
  Pubblicazione: (2024)
• Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression
  di: Lu Chen, et al.
  Pubblicazione: (2024)